Insider · CIK 0001368393

Baroldi Paolo

Reports to the SEC for 1 company · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001368393

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-01-03	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	22,500
2017-01-03	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	—	—	53,165
2017-01-03	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	58,165
2017-01-03	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	63,165
2017-01-03	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,500 sh	—	—	70,665
2017-01-03	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	+16.3K sh	$15.51	+$253K	54,365
2017-01-03	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	—	—	0
2017-01-03	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	5,000
2017-01-03	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	10,000
2016-02-12	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+70K sh	—	—	70,000
2016-02-12	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitA Award	SVP & Chief Medical Officer	AAward	+30K sh	—	—	30,000
2016-01-04	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	—	—	43,045
2016-01-04	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	48,045
2016-01-04	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	53,045
2016-01-04	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−12.4K sh	$8.96	−$111K	40,665
2016-01-04	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−12.5K sh	—	—	12,500
2016-01-04	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	10,000
2016-01-04	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	15,000
2015-03-10	VNDAVanda Pharmaceuticals Inc.S Sale	SVP & Chief Medical Officer	SSale	−8,940 sh	$10.54	−$94.2K	30,545
2015-03-10	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	15,000
2015-03-10	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	—	—	34,485
2015-03-10	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	—	—	39,485
2015-03-10	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−12.5K sh	—	—	25,000
2014-12-04	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+60K sh	—	—	60,000
2014-12-04	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitsA Award	SVP & Chief Medical Officer	AAward	+20K sh	—	—	20,000
2014-02-18	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	—	—	26,625
2014-02-18	VNDAVanda Pharmaceuticals Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−4,640 sh	$13.46	−$62.5K	21,985
2014-02-18	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−12.5K sh	—	—	37,500
2013-12-02	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitA Award	SVP & Chief Medical Officer	AAward	+20K sh	—	—	20,000
2013-12-02	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+60K sh	—	—	60,000
2013-04-15	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+150K sh	—	—	150,000
2013-04-15	VNDAVanda Pharmaceuticals Inc. · Restricted Stock UnitA Award	SVP & Chief Medical Officer	AAward	+50K sh	—	—	50,000
2007-01-30	VNDAVanda Pharmaceuticals Inc. · Non-Qualified Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+70K sh	—	—	70,000
2006-07-06	VNDAVanda Pharmaceuticals Inc. · Incentive Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+60.4K sh	—	—	60,427

Recent filings

Accepted (ET)
Jan 54
Vanda Pharmaceuticals Inc.0001209191-17-002226
SEC(opens sec.gov)
Feb 174
Vanda Pharmaceuticals Inc.0001209191-16-099404
SEC(opens sec.gov)
Jan 64
Vanda Pharmaceuticals Inc.0001209191-16-090123
SEC(opens sec.gov)
Mar 124
Vanda Pharmaceuticals Inc.0001209191-15-025769
SEC(opens sec.gov)

Companies

Vanda Pharmaceuticals Inc.SVP & Chief Medical OfficerVNDA

Address

2200 PENNSYLVANIA AVENUE SUITE 300E

WASHINGTON, DC, 20037